The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength

Wei Yao, Zhiqiang Cheng, Kurt J. Koester, Joel W. Ager, Mehdi Balooch, Aaron Pham, Solomon Chefo, Cheryl Busse, Robert O. Ritchie, Nancy E Lane

Research output: Contribution to journalArticle

42 Scopus citations

Abstract

The treatment of osteoporotic women with bisphosphonates significantly reduces the incidence of bone fractures to a degree greater than can be explained by an increase in bone mineral density. In this study, 18-month Fischer 344 rats were ovariectomized and treated with a single dose of risedronate (intravenous, iv, 500 μg), zoledronic acid (iv, 100 μg) or continuous raloxifene (2 mg/kg, po, 3×/week). High resolution microCT was used to measure lumbar vertebral bone microarchitecture, the degree of bone mineralization (DBM) and the distribution of mineral. Small angle X-ray scattering was used to investigate mineral crystallinity. We found prolonged estrogen deficiency, reduced trabecular bone volume, and increased micro architecture bone compression strength lowered the degree of mineralization. Treatment with resorptive agents (bisphosphonates > raloxifene) prevented the loss of mineralization, trabecular bone volume and bone compression strength. Crystal size was not changed with OVX or with anti-resorptive treatments. In conclusion, in the aged estrogen-deficient rat model, single intravenous doses of two bisphosphonates were effective in maintaining the compressive bone strength for 180 days by reducing bone turnover, and maintaining the DBM to a greater degree than with raloxifene.

Original languageEnglish (US)
Pages (from-to)804-812
Number of pages9
JournalBone
Volume41
Issue number5
DOIs
StatePublished - Nov 2007

Keywords

  • Bone mineralization
  • Compression strength
  • Intravenous bisphosphonates
  • OVX
  • Rat

ASJC Scopus subject areas

  • Physiology
  • Hematology

Fingerprint Dive into the research topics of 'The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength'. Together they form a unique fingerprint.

  • Cite this